Drug-induced serotonin syndrome

U.S. Pharmacist

Volumn 35, Issue 11, 2010, Pages

  Brown, Charles H ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; ANTIDEPRESSANT AGENT; BUSPIRONE; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CYPROHEPTADINE; DIAZEPAM; DULOXETINE; ELETRIPTAN; ERGOT ALKALOID; FLUOXETINE; FLUVOXAMINE; FROVATRIPTAN; LITHIUM; NARATRIPTAN; OLANZAPINE; PAROXETINE; PHENELZINE; RIZATRIPTAN; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; SUMATRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VENLAFAXINE; ZOLMITRIPTAN;

AGITATION; DEATH; DEPRESSION; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HARM REDUCTION; HEART ARREST; HUMAN; MENTAL DISEASE; MENTAL PATIENT; MONOTHERAPY; MORBIDITY; PATIENT EDUCATION; PHARMACIST; POLYPHARMACY; PSYCHOPHARMACOTHERAPY; REVIEW; RISK BENEFIT ANALYSIS; SEROTONIN SYNDROME; TREATMENT OUTCOME;

EID: 78449289418     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (37)

1. Facts about serotonin syndrome. Pharmacist's Letter/Prescriber's Letter. 2009;25:251002.
2. Watson WA, Litovitz TL, Rodgers GC, et al. 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2005;23:589-666.
3. Lerner BH. A case that shook medicine. Washington Post. November 28, 2006.
4. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-1120.
5. Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006;109:325-338.
6. Egberts AC, ter Borgh J, Brodie-Meijer CC. Serotonin syndrome attributed to tramadol addition to paroxetine therapy. Int Clin Psychopharmacol. 1997;12:181-182.
7. Manos G. Possible serotonin syndrome associated with buspirone added to fluoxetine. Ann Pharmacother. 2000;34:871-874. (Pubitemid 30471270)
8. Sclar DA, Robison LM, Skaer TL. Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome. Headache. 2008;48:126-129.
9. Lavery S, Ravi H, McDaniel WW, Pushkin YR. Linezolid and serotonin syndrome. Psychosomatics. 2001;42:432-434.
10. Gardner DM, Lynd LD. Sumatriptan contraindications and the serotonin syndrome. Ann Pharmacother. 1998;32:33-38.
11. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635-642. (Pubitemid 37063272)
12. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol. 1997;17:208-221. (Pubitemid 27261777)
13. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004;42:277-285. (Pubitemid 39166756)
14. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-1120.
15. Martin TG. Serotonin syndrome. Ann Emerg Med. 1996;28:520-526.
16. Sun-Edelstein C, Tepper SJ, Shapiro RE. Drug-induced serotonin syndrome: a review. Expert Opin Drug Saf. 2008;7:587-596.
17. Martin TG. Serotonin syndrome. Ann Emerg Med. 1996;28:520-526.
18. Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. CMAJ. 2003;168:1439-1442.
19. Bijl D. The serotonin syndrome. Neth J Med. 2004;62:309-313.
20. Keegan MT, Brown DR, Rabinstein AA. Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs. Anesth Analg. 2006;103:1466-1468.
21. Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry. 2008;30:284-287. (Pubitemid 351538958)
22. Bergeron L, Boulé M, Perreault S. Serotonin toxicity associated with concomitant use of linezolid. Ann Pharmacother. 2005;39:956-961. (Pubitemid 40570678)
23. Marplan (isocarboxazid) product information. Parsippany, NJ: Validus Pharmaceuticals; August 2007.
24. Keck PE Jr. Serotonin syndrome. Neuroleptic Malignant Syndrome Information Service. www.nmsis.org/content.asp? type=publications&src=pages/ relatedsyndromes.asp&title=serotonin+syndrome+and+other+related+syndromes. Accessed August 8, 2006.
25. Fisher AA, Davis MW. Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction. Ann Pharmacother. 2002;36:67-71. (Pubitemid 34052947)
26. Mason BJ, Blackburn KH. Possible serotonin syndrome associated with tramadol and sertraline coadministration. Ann Pharmacother. 1997;31:175-177.
27. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rule for serotonin toxicity. QJM. 2003;96:635-642. (Pubitemid 37063272)
28. Evans RW. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports. MedGenMed. 2007;9:48.
29. Taylor JJ, Wilson JW, Estes LL. Linezolid and serotonergic drug interactions: a retrospective survey. Clin Infect Dis. 2006;43:180-187.
30. Frank C. Recognition and treatment of serotonin syndrome. Can Fam Physician. 2008;54:988-992.
31. Rowley M, Riutort K, Shapiro D, et al. Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy. Neurocrit Care. 2009;11:88-93.
32. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2005;5:6-13. (Pubitemid 40220611)
33. Gnanadesigan N, Espinoza RT, Smith R, et al. Interaction of serotonergic antidepressants and opioid analgesics: is serotonin syndrome going undetected? J Am Med Dir Assoc. 2005;6:265-269.
34. Gan SH, Ismail R, Wan Adnan WA, Wan Z. Correlation of tramadol pharmacokinetics and CYP2D6*10 genotype in Malaysian subjects. J Pharm Biomed Anal. 2002;30:189-195. (Pubitemid 35013483)
35. Enggaard TP, Poulsen L, Arendt-Nielsen L, et al. The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6. Anesth Analg. 2006;102:146-150. (Pubitemid 43038298)
36. Lappin RI, Auchincloss EL. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med. 1994;331:1021-1022.
37. Reason J. Human error: models and management. BMJ. 2000;320:768-770.